Gene: ERG28
Official Full Name: ergosterol biosynthesis 28 homologprovided by HGNC
Gene Summary: Enables identical protein binding activity. Predicted to be involved in sterol biosynthetic process. Located in transport vesicle. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO31147 | ERG28 Knockout cell line (HeLa) | Human | ERG28 | 1:3~1:6 | Negative | Online Inquiry |
KO31148 | ERG28 Knockout cell line (HCT 116) | Human | ERG28 | 1:2~1:4 | Negative | Online Inquiry |
KO31149 | ERG28 Knockout cell line (HEK293) | Human | ERG28 | 1:3~1:6 | Negative | Online Inquiry |
KO31150 | ERG28 Knockout cell line (A549) | Human | ERG28 | 1:3~1:4 | Negative | Online Inquiry |
ERG28 Gene Knockout Cell Lines are genetically engineered cell lines that have had the ERG28 gene selectively inactivated or "knocked out" using techniques such as CRISPR/Cas9 gene editing. This process allows researchers to investigate the role of ERG28 in various biological pathways and diseases, particularly in models relevant to cancer and metabolic disorders. The functionality of these cell lines is primarily rooted in their ability to mimic specific cellular environments where the ERG28 gene contributes to gene expression, signal transduction, and metabolic regulation.
In scientific research and clinical settings, ERG28 Gene Knockout Cell Lines are invaluable for elucidating the mechanisms by which ERG28 mediates cellular processes. Researchers can utilize these cell lines to study the ramifications of ERG28 loss on cellular behavior, gene expression profiles, and disease progression, which can facilitate the identification of potential therapeutic targets. Their application is particularly significant in oncology, where understanding the function of tumor suppressors or oncogenes can lead to the development of new therapies.
One of the key advantages of using ERG28 Gene Knockout Cell Lines is their specificity and reliability compared to traditional methods of gene knockout, such as the use of viral vectors or chemical mutagens. These engineered cell lines provide a robust platform for reproducibility and a clearer understanding of gene function, thereby enhancing experimental integrity. Additionally, these cell lines are validated and characterized to ensure consistent performance across different experiments.
For researchers and clinicians alike, the availability of ERG28 Gene Knockout Cell Lines represents an essential tool in expanding their investigative capabilities in gene function and therapeutic interventions. The precision of gene editing technology inherent in these products opens avenues for advanced research, making them indispensable in the exploration of complex biological systems.
With our extensive experience in developing cutting-edge biological products, our company is committed to providing high-quality, reliable solutions that empower researchers to make significant strides in their discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.